Cohlhepp Ryan
SEC insider (Form 3/4/5 filer). CIK 0002034665. President, COO & Interim CEO at Bicara Therapeutics Inc. (BCAX). 44 reported Form 4/5 transactions since Sep 2024; latest on Sep 8, 2026. Located in BOSTON, MA.
Companies Cohlhepp Ryan has filed insider reports for
- Bicara Therapeutics Inc. (BCAX): Director, Officer, President, COO & Interim CEO
Cohlhepp Ryan
CIK: 0002034665
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Bicara Therapeutics Inc.
Discretionary Trading P&L
Holdings
Transaction History (44 total)
- Sep 8, 2026BCAX
Bicara Therapeutics Inc.
SaleDirect3.4K shares at avg. $23.43$81K - Sep 8, 2026BCAX
Bicara Therapeutics Inc.
SaleDirect14.1K shares at avg. $22.77$320K - Sep 8, 2026BCAX
Bicara Therapeutics Inc.
ExerciseDirect17.5K shares at avg. $3.79$66K - Aug 10, 2026BCAX
Bicara Therapeutics Inc.
ExerciseDirect18.8K shares at avg. $3.79$71K - Aug 10, 2026BCAX
Bicara Therapeutics Inc.
SaleDirect18.8K shares at avg. $27.98$525K - Jul 9, 2026BCAX
Bicara Therapeutics Inc.
SaleDirect536 shares at avg. $29.00$16K - Jul 8, 2026BCAX
Bicara Therapeutics Inc.
SaleDirect22.8K shares at avg. $28.76$657K - Jul 8, 2026BCAX
Bicara Therapeutics Inc.
SaleDirect4.3K shares at avg. $29.80$128K - Jul 8, 2026BCAX
Bicara Therapeutics Inc.
ExerciseDirect18.8K shares at avg. $3.79$71K - Jul 8, 2026BCAX
Bicara Therapeutics Inc.
SaleDirect1.1K shares at avg. $30.35$33K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 8, 2026 | BCAX Bicara Therapeutics Inc. | Sale | 3,442 | $23.43 | $80,663 | Direct |
| Sep 8, 2026 | BCAX Bicara Therapeutics Inc. | Sale | 14,058 | $22.77 | $320,053 | Direct |
| Sep 8, 2026 | BCAX Bicara Therapeutics Inc. | Exercise | 17,500 | $3.79 | $66,322 | Direct |
| Aug 10, 2026 | BCAX Bicara Therapeutics Inc. | Exercise | 18,750 | $3.79 | $71,059 | Direct |
| Aug 10, 2026 | BCAX Bicara Therapeutics Inc. | Sale | 18,750 | $27.98 | $524,533 | Direct |
| Jul 9, 2026 | BCAX Bicara Therapeutics Inc. | Sale | 536 | $29.00 | $15,544 | Direct |
| Jul 8, 2026 | BCAX Bicara Therapeutics Inc. | Sale | 22,833 | $28.76 | $656,652 | Direct |
| Jul 8, 2026 | BCAX Bicara Therapeutics Inc. | Sale | 4,306 | $29.80 | $128,302 | Direct |
| Jul 8, 2026 | BCAX Bicara Therapeutics Inc. | Exercise | 18,750 | $3.79 | $71,059 | Direct |
| Jul 8, 2026 | BCAX Bicara Therapeutics Inc. | Sale | 1,075 | $30.35 | $32,632 | Direct |
1-10 of 44 transactions